IMVT

IMVT

USD

Immunovant Inc. Common Stock

$24.190+0.810 (3.464%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$23.380

Haut

$24.530

Bas

$23.310

Volume

1.45M

Fondamentaux de l'Entreprise

Capitalisation Boursière

4.2B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.71M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $12.72Actuel $24.190Haut $32.1

Actualités Connexes

GlobeNewswire

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.

Voir plus
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Analyst Upgrades

Truist Securities Initiates Coverage On Immunovant with Hold Rating, Announces Price Target of $16

Truist Securities analyst Danielle Brill initiates coverage on Immunovant with a Hold rating and announces Price Target of $16.

Voir plus
Truist Securities Initiates Coverage On Immunovant with Hold Rating, Announces Price Target of $16

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.